SCHEMBL24063677

SCHEMBL24063677

C/C=C\N(CC)c1cccc2c1oc1ccccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.38
▸ MAPT P10636 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ DRD4 P21917 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26708494 0.84 ALOX5 (0.35) ALOX5MAPTNPSR1TSHRAHR
SCHEMBL16559095 0.79 MAPT (0.47) ALOX5MAPTNPSR1TSHRAHR
SCHEMBL24864802 0.77 ALOX5 (0.42) ALOX5MAPTNPSR1TSHRAHR
SCHEMBL22857649 0.73 ALOX5 (0.41) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL19929766 0.73 ALOX5 (0.43) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL6372657 0.72 ALOX5 (0.45) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL14295465 0.72 ALOX5 (0.42) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL23046767 0.70 ALOX5 (0.44) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL15306316 0.70 ALOX5 (0.41) ALOX5MAPTAHRSMN1; SMN2MEN1
SCHEMBL15178580 0.70 ALOX5 (0.41) ALOX5MAPTAHRSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230309396-A1 Host Materials for Electroluminscent Devices UNIVERSAL DISPLAY CORPORATION 2023-09-28 — — US disclosed
US-20220144869-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS UDC IRELAND LIMITED (IE) 2022-05-12 — — US disclosed
US-11189806-B2 Heteroleptic carbene complexes and the use thereof in organic electronics UDC IRELAND LIMITED (IE) 2021-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230309396-A1 Host Materials for Electroluminscent Devices CRHR1, CRHR2, CRH ALOX5 2710/4885MAPT 4201/4885NPSR1 246/4885
US-20220144869-A1 HETEROLEPTIC CARBENE COMPLEXES AND THE USE THEREOF IN ORGANIC ELECTRONICS OCIAD2, OCIAD1, CLTB ALOX5 2557/4885MAPT 58/4885NPSR1 2172/4885
US-11189806-B2 Heteroleptic carbene complexes and the use thereof in organic electronics OCIAD2, OCIAD1, CLTB ALOX5 3079/4885MAPT 100/4885NPSR1 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback